AGO1 and fungal infectious disease: AGO1 knockout mutants exhibited reduced disease symptoms and lowered fungal biomass, whereas wild‐type and miR168b mutants showed greater susceptibility (Shen et al., 2014), highlighting the role of the miR168‐AGO1 module in promoting fungal infection.